Home » AFFYMETRIX GRANTS EPIGENOMICS NONEXCLUSIVE ACCESS TO ITS MICRO ARRAY TECHNOLOGY
AFFYMETRIX GRANTS EPIGENOMICS NONEXCLUSIVE ACCESS TO ITS MICRO ARRAY TECHNOLOGY
Tuesday, Affymetrix Inc. said that it granted Epigenomics AG non-exclusive access to its microarray technology to develop and market microarray-based in-vitro diagnostic or IVD tests for oncology and other indications.
Trading Markets Live
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct